InvestorsHub Logo
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: robbie1165 post# 423

Monday, 08/17/2009 5:04:45 AM

Monday, August 17, 2009 5:04:45 AM

Post# of 3993
I attend their presentations once in a while and the one at Canaccord dids not differ much except the joke about calling prGCD 'carrotzyme', sounds better in Hebrew. Only new detail I noticed here was Aviezer's comment on the switching study, which enrolls much faster now due to the Cerezyme shortage.
I don't have new insights, they are all old smile
There are several potential upside drivers for 2009 regarding PLX itself: IRB approvals, phase III data are expected in Oct. and an NDA submission by year-end (only next year in EU), commercial collaboration for prGCD could also occur soon. External factors - we didn't yet see full data from Shire and any hiccup there may be positive for PLX. Same goes for the Cerezyme shortage.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PLX News